SSIM
FBIO icon

Sheets Smith Investment Management’s Fortress Biotech FBIO Stock Holding History

Sheets Smith Investment Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$270K Buy
+73,142
New +$185K 0.18% 104

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SAM
Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return

Sheets Smith Investment Management's FBIO Position: Q3 2025 in Review

Sheets Smith Investment Management opened a new position in Fortress Biotech (FBIO) in Q3 2025: 73,142 shares worth $270K. The stake represents 0.18% of the portfolio and ranks #104 among its holdings.

56 funds tracked by Wall St. Rank hold FBIO as of Q3 2025.

  • Sheets Smith Investment Management held 73,142 shares of Fortress Biotech worth $270K as of Q3 2025.
  • Fortress Biotech was a new Sheets Smith Investment Management position in Q3 2025.
  • Fortress Biotech made up 0.18% of Sheets Smith Investment Management's portfolio in Q3 2025, its #104 holding.
  • 56 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2025.

Based on Sheets Smith Investment Management's 13F filing for Q3 2025, filed 8 Oct 2025.